header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-11180
Fish name: cyp26a1rw716/rw716
Genotype: cyp26a1rw716/rw716
Targeting Reagent: none
HUMAN DISEASE MODELED by cyp26a1rw716/rw716
Human Disease Conditions Citations
holoprosencephaly standard conditions Gongal et al., 2008
GENE EXPRESSION
Gene expression in cyp26a1rw716/rw716
RNA expression
Expressed Gene Structure Conditions Figures
aldh1a2 standard conditions Fig. 5 with image from Drummond et al., 2013
arxa standard conditions Fig. 5 from Gongal et al., 2008
barhl2 standard conditions Fig. 5 from Gongal et al., 2008
cyp26b1 control Fig. 5 with image from Hernandez et al., 2007
chemical treatment: all-trans-retinoic acid Fig. 5 with image from Hernandez et al., 2007
cyp26c1 control Fig. 5 with image from Hernandez et al., 2007
chemical treatment: all-trans-retinoic acid Fig. 5 with image from Hernandez et al., 2007
dhrs3a standard conditions Fig. 5 with image from Feng et al., 2010
dlx2a chemical treatment: 4-(diethylamino)benzaldehyde, chemical treatment: all-trans-retinoic acid Fig. 4 with image from Hernandez et al., 2007
egr2b control Fig. S1 with image from Rydeen et al., 2014
Fig. 8 with image from Feng et al., 2010
Fig. 4 with imageFig. 5 with image from Hernandez et al., 2007
chemical treatment: 4-(diethylamino)benzaldehyde Fig. 4 with imageFig. 5 with imageFig. 6 with imageFig. S2 with image from Hernandez et al., 2007
en2a standard conditions Fig. S1 with image from Rydeen et al., 2014
en2b chemical treatment: 4-(diethylamino)benzaldehyde, chemical treatment: all-trans-retinoic acid Fig. 4 with image from Hernandez et al., 2007
hnf1ba chemical treatment: all-trans-retinoic acid Fig. S2 with image from Hernandez et al., 2007
hoxb1a chemical treatment: 4-(diethylamino)benzaldehyde, chemical treatment: all-trans-retinoic acid Fig. 4 with image from Hernandez et al., 2007
hoxb4a standard conditions Fig. S1 with image from Rydeen et al., 2014
hoxd4a control Fig. 8 with image from Feng et al., 2010
Fig. 4 with image from Hernandez et al., 2007
chemical treatment: 4-(diethylamino)benzaldehyde Fig. 4 with imageFig. 6 with image from Hernandez et al., 2007
ins control Fig. 3 with image from Kinkel et al., 2009
myod1 chemical treatment: 4-(diethylamino)benzaldehyde, chemical treatment: all-trans-retinoic acid Fig. 4 with image from Hernandez et al., 2007
nkx2.1 standard conditions Fig. 5 from Gongal et al., 2008
nkx2.4b standard conditions Fig. 5 from Gongal et al., 2008
otx2b chemical treatment: 4-(diethylamino)benzaldehyde, chemical treatment: all-trans-retinoic acid Fig. 4 with image from Hernandez et al., 2007
pax2a control Fig. 8 with image from Feng et al., 2010
Fig. 4 with image from Hernandez et al., 2007
chemical treatment: 4-(diethylamino)benzaldehyde Fig. 4 with imageFig. 6 with imageFig. S2 with image from Hernandez et al., 2007
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in cyp26a1rw716/rw716
Phenotype Conditions Figures
heart edematous, abnormal standard conditions Fig. S2 with image from Rydeen et al., 2014
hindbrain edematous, abnormal standard conditions Fig. S2 with image from Rydeen et al., 2014
pancreas increased length, abnormal control Fig. 3 with image from Kinkel et al., 2009
pancreas mislocalised anteriorly, abnormal control Fig. 3 with image from Kinkel et al., 2009
pancreas development process quality, abnormal control Fig. 3 with image from Kinkel et al., 2009
pectoral fin morphology, abnormal standard conditions Fig. S6 from He et al., 2011
pectoral fin development disrupted, abnormal standard conditions Fig. S6 from He et al., 2011
whole organism morphology, normal standard conditions Fig. S3 from Gongal et al., 2008

CITATIONS  (10)